Magnetic Resonance - Technology Information Portal Welcome to MRI Technology
Info
  Sheets

Out-
      side
 



 
 'LumenHance®' 
SEARCH FOR    
 
  2 3 5 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Result : Searchterm 'LumenHance®' found in 1 term [] and 2 definitions []
1 - 3 (of 3)     
Result Pages : [1]
MRI Resources 
Diffusion Weighted Imaging - Mass Spectrometry - MRI Reimbursement - Veterinary MRI - MR Guided Interventions - Research Labs
 
LumenHance®InfoSheet: - Contrast Agents - 
Intro, Overview, 
Characteristics, 
Types of, 
etc.MRI Resource Directory:
 - Contrast Agents -
 
Oral administration of this liposomal encapsulated manganese chloride results in a reduction of the T1 relaxation time causing enhanced signal on T1 weighted MR images. Bracco received marketing approval in December 1997 in the United States, but marketing state is still uncertain.

See also Classifications, Characteristics, etc.
Drug Information and Specification
NAME OF COMPOUND
MnCl2, Manganese chloride tetrahydrate
CENTRAL MOIETY
Mn2+
CONTRAST EFFECT
T1, Predominantly positive enhancement
Paramagnetic
PHARMACOKINETIC
Gastrointestinal
PREPARATION
Powder for reconstitution
INDICATION
Bowel marking
DEVELOPMENT STAGE
For sale
DISTRIBUTOR
See below
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE
NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT!
Distribution Information
TERRITORY
TRADE NAME
DEVELOPMENT
STAGE
DISTRIBUTOR
LumenHance®
for sale
spacer
 
• Share the entry 'LumenHance®':  Facebook  Twitter  LinkedIn  
MRI Resources 
Education - MRI Training Courses - Calculation - Blood Flow Imaging - Shielding - Spectroscopy
 
ImaRx LLCMRI Resource Directory:
 - Manufacturers -
 
www.imarx.com Founded in 1991, ImaRx Pharmaceutical Corp. designs, develops and markets pharmaceuticals for medical imaging (MRI, ultrasound and computed tomography) for the radiological imaging industry.
ImaRx Pharmaceutical Corp., announced 1999 that it has been acquired by E.I DuPont de Nemours and Co., Inc.. The terms of the acquisition provide a royalty-free licensing arrangement with a newly-formed company, ImaRx LLC ("LLC"), to pursue and develop new products and technologies for drug and gene delivery independent from DuPont. Yamanouchi Pharmaceutical Co. Ltd., ImaRx' licensee for Asian territories for this product, will continue to develop the product in Asia as DuPont's licensee. ImaRx LLC will have ownership of all other targeted and therapeutic products previously owned by ImaRx, including imaging products outside of diagnostic ultrasound imaging and two other imaging products, SonoRx® and LumenHance®, which are both FDA approved and licensed to BRACCO Diagnostics.

MRI Contrast Agents:
Contact Information
MAIL
ImaRx LLC
1635 East 18th Street
Tucson AZ 85719-6803
USA
PHONE
+1-520-770-1259
spacer
MRI Resources 
Sequences - MRCP - RIS - Education - Directories - MRI Reimbursement
 
Bracco Diagnostics, Inc.MRI Resource Directory:
 - Manufacturers -
 
www.bdi.bracco.com The company is a member of the Bracco Group, a highly innovative healthcare group and world leader in global integrated solutions for the diagnostic medical imaging field. The Bracco Group is headquartered in Milan, Italy. Its North American operations consist of Bracco Diagnostics and Bracco Research USA, both located in Princeton, New Jersey. Bracco Diagnostics is one of the fastest growing developers and marketers of diagnostic pharmaceuticals in North America, with products for various imaging applications, including Isovue® (iopamidol - X-ray contrast agent), ProHance® (gadoteridol - MRI contrast agent), SonoVue® (ultrasound contrast agent) and nuclear medicine products.
Gadoteridol has been available in Europe and the USA for several years. Holder of the Marketing Authorization: Bracco International B.V. - Strawinskylaan 3051 - 1077 ZX Amsterdam The Netherlands. (Contact: Kirk Deeter, Phone: +NL-303-838-8708)

MRI Contrast Agents:
•
•
•
•
Contact Information
Please see Bracco Diagnostics, Inc.'s
spacer

• View the DATABASE results for 'Bracco Diagnostics, Inc.' (2).Open this link in a new window

 
Further Reading:
  News & More:
FDA Expands Pediatric Age Range for MultiHance Contrast Agent
Tuesday, 30 January 2018   by www.empr.com    
BRACCO DIAGNOSTICS' MULTIHANCE EARNS FDA APPROVAL
Wednesday, 24 November 2004   by salesandmarketingnetwork.com    
MRI Resources 
Implant and Prosthesis pool - Services and Supplies - Health - IR - Image Quality - Case Studies
 
     1 - 3 (of 3)     
Result Pages : [1]
 Random Page
 
Share This Page
FacebookTwitterLinkedIn

MR-TIP    
Community   
User
Pass
Forgot your UserID/Password ?    



New acceleration techniques will :
reduce scan times 
cause artifacts 
increase expenses 
be useful if you have a lot of experience 
doesn't do much 
never heard of 

Look
      Ups





MR-TIP.com uses cookies! By browsing MR-TIP.com, you agree to our use of cookies.

Magnetic Resonance - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • Medical-Ultrasound-Imaging • 
Copyright © 2003 - 2024 SoftWays. All rights reserved. [ 29 March 2024]
Terms of Use | Privacy Policy | Advertising
 [last update: 2024-02-26 03:41:00]